Fig. 8From: Chitosan nanoparticle-mediated co-delivery of shAtg-5 and gefitinib synergistically promoted the efficacy of chemotherapeutics through the modulation of autophagyTumor growth inhibition and histological examination of tumor sections in nude mice bearing PLC tumors following treatment with different formulations. a Images of a xenograft tumor model in vivo following treatment with PBS, free gefitinib, free gefitinib and shAtg-5, gefitinib NPs, and gefitinib/shAtg-5 NPs for 3 weeks. b Tumor volume curves after the animals were treated by different preparations. The results were expressed as mean ± SD (n = 5). c Histological examination of tumor sections (20 days after the first treatment). Nuclei were stained blue, while the extracellular matrix and cytoplasm were stained red via H&E staining. For the immunohistochemistry staining, blue stains showed the nuclei, and brown stains in the cytoplasm indicated protein expression in tumor cells. Scale bar for H&E staining: 40 μm; scale bar for immunohistochemistry staining: 20 μmBack to article page